Durex sales are declining in China as the government's efforts to increase birth rates reduce demand for contraceptives. The condom manufacturer faces headwinds from policies designed to encourage larger families and higher population growth in the world's most populous nation.

China's birth rate initiatives include everything from extended parental leave to financial incentives for having children. These measures directly counteract demand for family planning products, creating an unusual market dynamic where government policy works against consumer goods sales.

The contraceptive market in China represents a significant revenue stream for Durex, which has positioned itself as the leading brand in the country. Reduced contraceptive usage translates to measurable revenue impacts for the company's operations in the region.

This represents a rare case where demographic policy directly conflicts with commercial interests. Companies in the reproductive health sector now face navigating between compliance with government goals and maintaining their business model in one of the world's largest consumer markets.